Guardant Health Leads the Way in Blood-Based Single Cancer Screening
As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.
Researchers advance non-invasive cancer detection methods
Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...
Cure Today3d
UGN-102 Shows Complete Response Rates in Low-Grade Bladder Cancer
Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...
Cure Today4d
mpMRI Improves Initial Staging in Suspected Muscle-Invasive Bladder Cancer
Among patients with suspected MIBC, the incorporation of mpMRI for initial staging prior to transurethral resection of ...
UroToday6d
ASCO GU 2025: Beneath the Surface: Unleashing the Potential of ctDNA across the Spectrum of Urothelial Carcinoma
American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Panning for Gold: The Role of ctDNA as ...
Business Wire7d
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...
hospitalhealthcare8d
Expediting muscle-invasive bladder cancer treatment using multiparametric MRI
MRI for the initial staging of MIBC is both feasible and beneficial in reducing treatment delays compared to TURBT, a new study shows.
TMCnet10d
Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests' Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium
"The scale and scope of data to be presented at the ASCO GU meeting underscore the impact our whole-transcriptome-based Decipher tests are having in treating patients with urologic cancers, and how ...
SurvivorNet14d
Biopsy Isn’t Fun — But Can Put Your Mind at Ease
Getting a prostate biopsy is a fairly short procedure and you’ll be home the same day. A needle is inserted into the rectum in order to reach the prostate gland and MRI imaging can be used to guide ...
Frontiers19d
Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
Our study's goal was to screen novel biomarkers that could accurately predict the progression and prognosis of bladder cancer (BC). Firstly, we used the Gene Expression Omnibus (GEO) dataset GSE37815 ...
UroToday23d
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer.
This study aimed to clinically validate the six-gene prognostic molecular clinical risk score (MCRS) for the prediction of aggressive prostate cancer in diagnostic biopsy tissue. MCRS was evaluated in ...
verywellhealth23d
The Relationship Between IBS and Bladder Problems
IBS and bladder problems may be linked according to research. Bladder issues, like frequent urination, are commonly diagnosed in addition to irritable bowel syndrome (IBS). The overlap between bladder ...